Mikhail Blagosklonny, the Eye Opener

Mikhail Blagosklonny is a man that has made a career out of research and teaching particularly in the field of Oncology. Above all, Mikhail Blagosklonny is a renowned philanthropist who wants to leave the world better and more sustainable. Through his research, Mikhail Blagosklonny has been finding better and efficient ways of treating illnesses. Although Mikhail’s medical theories are in the pilot stage, it gets anticipated that they will in future help people gain access to quality healthcare and treatment at a subsidized cost.From the very beginning, Blagosklonny’s real concern has been the disciplines of cancer and aging. As a dedicated researcher, Mikhail has always been looking for a connection between the two aspects, since it has come to his attention that a vast of majority of cancer patients also happen to be old. By carrying out his research, Mikhail Blagosklonny believes that he will one day hit the jackpot.As a university professor, Mikhail has not been shy of sharing his research findings with his many students. Also, Blagosklonny has spent countless numbers of hours explaining his many theories on cancer and aging to his peers. In so doing, Mikhail Blagosklonny has been able to transfer his knowledge to young people, insights that will live long after his time.

By sharing what he knows with current generations, Mikhail believes that such knowledge will be detrimental to future research. After years of laboratory observations and testing, Dr. Mikhail Blagosklonny has found that Rapamycin is more than a super drug. Since 1972, Rapamycin, commonly known as Sirolimus has found much use as an antibiotic.However, the use of Rapamycin as an anti-fungal agent has since gotten stopped after it got discovered that Sirolimus was powerful enough to act as an immuno-suppressor as well as an anti-proliferator. Presently, Sirolimus has found its way to the operating rooms where it gets used to prevent organ transplant rejection. Apart from that, Rapamycin is commonly used to treat cancer as well as a rare disease that affects the lungs.To date, Mikhail Blagosklonny ranks Rapamycin as one of the best drugs to ever get invented. Apart from its immunosuppressant properties, Sirolimus is also ideal for treating people suffering from the hemolytic-uremic syndrome. In so doing, the drug helps prevent renal failure thus paving the way for a highly successful kidney transplant.

Also, Mikhail has found out that Rapamycin comes in handy especially for the treatment of Lymphangioleiomyomatosis, a rare lung disease that commonly affects women of childbearing age. Other physiological and biological anomalies that Rapamycin helps correct include coronary scent coating, cancer, tuberous sclerosis complex, facial angiofibromas, aging, Alzheimer’s disease, muscular dystrophy, and systemic lupus erythematosus. Although the impact of Rapamycin on aging is still under research, Mikhail Blagosklonny feels that a connection between the drug, aging, and cancer will get discovered sooner than later. Since the results seem promising, Blagosklonny believes that by increasing an individual’s lifespan, that person will get protected from deadly diseases like cancer that commonly affect the senior citizens. From the preceding, Mikhail Blagosklonny has done more than a lot to help society come up with cheaper alternatives in the cure and treatment of cancer.

Leave a Reply

Your email address will not be published. Required fields are marked *